2) receptor agonists
受体激动剂
1.
Purpose To build a three dimensional structure activity relationship model of the title compounds and gain further insights into requirements for potential nonsteroidal progesterone receptor agonists.
目的 建立非甾体类孕酮受体激动剂5-亚苄基-1,2-二氢-5H-苯并吡喃并[3,4-f]喹啉衍生物的三维 定量构效模型,为设计高效的非甾体类孕酮受体激动剂提供理论依据。
3) retinoic acid receptor
维甲酸受体
1.
Synergistic effects of acitretin and narrow-band ultraviolet-B in inducing retinoic acid receptor gamma mRNA expression in normal human keratinocytes;
依曲替酸和窄谱中波紫外线对正常人角质形成细胞维甲酸受体γ mRNA表达的协同影响
2.
Establishment of high-throughput drug screening model targeting retinoic acid receptor in cells;
维甲酸受体为靶点的高通量药物筛选细胞模型的建立
3.
Mutation in exon 6 of retinoic acid receptor alpha in patients with psoriasis vulgaris;
寻常型银屑病患者维甲酸受体α基因第6外显子碱基突变
4) retinoic acid receptors
维甲酸受体
1.
Comparative study on the expression of retinoic acid receptors (RARs) in the four cell lines of human pulmonary carcinoma;
不同组织学类型人肺癌细胞系的维甲酸受体表达
2.
A comparative study of the expression of retinoic acid receptors (RARs) in the four cell lines of human pulmonary carcinoma;
四株肺癌细胞系的维甲酸受体表达的研究
5) receptor agonist of glutamate
谷氨酸受体激动剂
6) M1 receptor agonist
M1受体激动剂
1.
3-(3-Chloro-1,2,5-thiadiazol-4-yl)pyridine,which is a key intermediate of selective M1 receptor agonist xanomeline,was synthesized from 3-pyridine carboxaldehyde,sodium cyanide,and sulfur chloride.
以3-吡啶甲醛为原料,与氰化钠、一氯化硫反应合成选择性M1受体激动剂占诺美林的关键中间体3-(3-氯-1,2,5-噻二唑-4-基)吡啶,目标化合物的结构经1H-NMR谱确证。
2.
In this paper, the recent research progress in drugs for treatment of AD and their mechanisms are reviewed, including AChE inhibitor,M1 receptor agonist,antioxidants,nerve growth factor,calcium regulator and so on.
综述了近5年来治疗AD药物的研究进展,根据作用机制的不同对临床应用的抗AD和有促智活性的药物进行分类详述,主要分为乙酰胆碱酯酶抑制剂等改善胆碱功能的药物、M1受体激动剂、抗氧化药物、消炎镇痛药物、抑制Aβ蛋白形成的药物、神经生长因子、钙调节剂、晚期糖基化终产物(AGE)抑制剂以及中药复方等几类。
补充资料：维甲酸
分子式：C20H28O2
分子量：暂无
CAS号：302-79-4
性质：暂无
制备方法：暂无
用途：用于异常型痤疮、鱼磷病和异常型银屑病。
分子量：暂无
CAS号：302-79-4
性质：暂无
制备方法：暂无
用途：用于异常型痤疮、鱼磷病和异常型银屑病。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条